Oncostatin M down-regulates basal and induced cytochromes P450 in human hepatocytes

Journal of Pharmacology and Experimental Therapeutics

Volumn 285, Issue 1, 1998, Pages 127-134

  Guillén, M Isabel ^a   Donato, M Teresa ^a   Jover, Ramiro ^a   Castell, José V ^a   Fabra, R ^b   Trullenque, R ^b   Gómez Lechón, M José ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b Hospital General de Valencia   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

3 METHYLCHOLANTHRENE; CYTOCHROME P450; CYTOCHROME P450 ISOENZYME; DEXAMETHASONE; GRANULOCYTE COLONY STIMULATING FACTOR; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M; PHENACETIN O DEETHYLASE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 11; RECOMBINANT INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; LIVER CELL; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ADULT; AGED; CYTOCHROME P-450 CYP1A2; CYTOCHROME P-450 ENZYME SYSTEM; CYTOKINES; DOWN-REGULATION; ENZYME INDUCTION; FEMALE; GROWTH INHIBITORS; HUMANS; LIVER; MALE; MIDDLE AGED; MIXED FUNCTION OXYGENASES; NITRITES; ONCOSTATIN M; PEPTIDES; PROTEINS;

EID: 0031969504     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Abdel-Razzak Z, Lover P, Fautrel A, Gautier JG, Corcos L, Turlin B, Beaunem P and Guillouzo A (1993) Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol 44:707-715.
2. Abdel-Razzak Z, Corcos L, Fautrel A, Campion JP and Guillouzo A (1994) Transforming growth factor-β1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture. Mol Pharmacol 46:1100-1110.
3. Ansher S, Puri RK, Thompson WC and Habig WH (1992) The effects of interleukin 2 and α-interferon administration on hepatic drug metabolism in mice. Cancer Res 52:262-266.
4. Barker CW, Fagan JB and Pasco D (1992) Interleukin-1β supresses the induction of P4501A1 and P4501A2 mRNAs in isolated hepatocytes. J Biol Chem 267:8050-8055.
5. Billiar TR, Curran RD, Stuehr DJ, Stadier J, Simmons RL and Murray SA (1990) Inducible cytosolic enzyme activity for the production of nitrogen oxides form L-arginine in hepatocytes. Biochem Biophys Res Commun 168:1034-1040.
6. Brown TJ, Rowe JM, Liu JW and Shoyab M (1991) Regulation of IL-6 expression by oncostatin M. J Immunol 174:2175-2180.
7. Castell JV, Gómez-Lechón MJ, David M, Fabra R, Trullenque R and Heinrich PC (1990) Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12:1179-1186.
8. Chen YL, Florentin I, Batt AM, Ferrari L, Giroud JP and Chauvelot-Moachon L (1992) Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat. Biochem Pharmacol 44:137-148.
9. Chen JQ, Strom A, Gustafsson JA and Morgan ET (1995) Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: Comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6. Mol Pharmacol 47:940-947.
10. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
11. Clark MA, Bing BA, Gottschall PE and Williams JF (1995) Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes. Biochem Pharmacol 49:97-104.
12. Craig PI, Mehta I, Murray M, McDonald D, Astrom A, van der Meide PH and Farrell GC (1990) Interferon down regulates the male-specific cytochrome P450IIIA2 in rat liver. Mol Pharmacol 38:313-318.
13. Donato MT, Gómez-Lechón MJ and Castell JV (1993b) A microassay for measuring cytochrome P450IA1 and P450IIB1 activities in intact human and rat hepatorytes cultured on 96-well plates. Anal Biochem 213:29-33.
14. Donato MT, Guillén MI, Jover R, Castell JV and Gómez-Lechón (1997) Nitric oxide-mediated inhibition of cytochrome P450 by interferon-γ in human hepatocytes. J Pharmacol Exp Ther 281:484-490.
15. Donato MT, Herrero E, Gómez-Lechón MJ and Castell JV (1993a) Inhibition of monooxygenase activities in human hepatocytes by interferons. Toxicol In Vitro 7:481-485.
16. Fukuda Y and Sassa S (1994) Suppression of cytochrome P450IA1 by interleukin-6 in human hepG2 hepatoma cells. Biochem Pharmacol 47:1187-1195.
17. Gearing DP, Comeau MR, Friend DJ, Gimpel SD, Thut CJ, McGourty J, Brasher KK, King JA, Gillis S, Mosley B, Ziegler SF and Cosman (1992) The IL-6 signal transducer, pg130: An oncostatin M receptor and affinity converter for the LIF receptor. Science 255:1434-1437.
18. Geisterfer M, Richards CD and Gauldie J (1995) Cytokines oncostatin M and interleukin 1 regulate the expression of the IL-6 receptor (gp80, gp130). Cytokine 7:503-509.
19. Ghezzi P, Bianchi M, Gianera L, Landolfo S and Salmona M (1985) Role of reactive oxygen intermediates in the interferon-media ted depression of hepatic drug metabolism and protective effect of N-acetylcysteine. Cancer Res 45:3444-3447.
20. Gómez-Lechón MJ, López P, Donato T, Montoya A, Larrauri A, Giménez P, Trullenque R, Fabra R and Castell JV (1990) Culture of human hepatocytes from small surgical biopsies: Biochemical characterization and comparison with in vivo. In Vitro Cell Der Biol 26:67-74.
21. Gonzalez FJ (1990) Molecular genetics of the P-450 superfamily. Pharmacol Ther 45:1-38.
22. Gonzalez FJ, Schmid BJ, Umeno M, McBride OW, Hardwick JP, Meyer UA, Gelboin HV and Idle JR (1988) Human P450PCN1; sequence, chromosome localization, and direct evidence through cDNA expression that P450PCN1 is nifedipine oxidase. DNA 7:79-86.
23. Grove RI, Mazzuco CE, Radka SF, Shoyab M and Keiner PA (1991) Oncostatin M upregulates low density lipoprotein receptors in HepG2 cells by a novel mechanism. J Biol Chem 266:194-199.
24. Hibi M, Nakajima K and Hirano T (1996) IL-G cytokine family and signal transduction: A model of the cytokine system J Mol Med 74:1-12.
25. Horn D, Fitzpatrick M, Gompper PT, Ochs V, Bolton-Hansen M, Zarling J, Todaro GJ and Linsley PS (1990) Regulation of ce11 growth by recombinant oncostatin-M. Growth Factora 2:157-165.
26. Jaiswal AK, Nebert DW and Gonzalez FJ (1986) Human P3(450): cDXA and complete amino acid sequence. Nucleic Acids Res 14:6773-6774.
27. Kishimoto T, Taga T and Akira S (1994) Cytokine signal transduction. Cell 76:253-262.
28. Koj A (1985) Liver response to inflammation and synthesis of acute-phase plasma proteins. Part III. In The Acute Phase Response to Injury and Infection: Vol. 10. A. H. Gordon and A. Koj, eds. pp. 139-144, Elsevier, Amsterdam.
29. Kushner I (1982) The phenomenon of the acute phase response. Ann NY Acad Sci 389:39-48.
30. Kushner I and Mackiewicz A (1987) Acute phase proteins as disease markers. Dis Markers 5:1-11.
31. Liu J, Modrell B, Aruffo A, Maken JS, Taga T, Yasukawa K, Murakami M, Kishimoto T and Shoyab M (1992) Interleukin-6 signal tranducer gp130 mediates oncostatin M signaling. J Biol Chem 267:16763-16766.
32. Lowry OH, Rosebrough NJ, Farr AL and Randall R (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
33. Morgan ET (1993) Down-regulation of multiple cytochrome P450 gene products by inflammatory mediators in vivo: Independence from the hypothalamo-pituitary axis. Biochem Pharmacol 45:415-419.
34. Morgan ET, Thomas KB, Swanson R, Vales T, Hwang J and Wright K (1994) Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver. Biochem Biophys Acta 1219:475-483.
35. Mosley B, De-Imus C, Friend D, Boiani N, Thoma B, Park LS and Cosman D (1996) Dual oncostatin M (OSM) receptors: Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation. J Biol Chem 271: 32635-32643.
36. Muntané-Relat J, Ourlin JC, Domergue J and Maurel P (1995) Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture. Hepatology 22:1143-1153.
37. Nicola NA (1994) An introduction to the cytokines. In Cytokines and Their Receptors, ed. by N. A. Nicola, pp. 1-7, Oxford University Press, Oxford.
38. Nussler AK, Di Silvio M, Billiar TR, Hoffman RA, Geller DA, Selby R, Madariaga J and Simmons RL (1992) Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J Exp Med 176:261-264.
39. Persico MG, Viglietto G, Martini G, Toniolo D, Paonessa G, Moscatelli C, Dono R, Vulliamy T, Luzzatto L and D'Urso M (1986) Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: Primary structure of the protein an unusual 5′ non-coding region. Nucleic Acids Res 14:2511-2522.
40. Richards CD, Brown TJ, Shoyab M, Baumann H and Gauldie J (1992) Recombinant oncostatin M stimulates the production of acute phase proteins in hepG2 cells and rat primary hepatocytes in vitro. J Immunol 148:1731-1736.
41. Richards CD and Agro A (1994) Interaction between oncostatin M, interleukin 1 and prostaglandin E2 in induction of IL-6 expression in human fibroblasts. Cytokine 6:40-47.
42. Richards CD and Gauldie J (1994) Xenobiotics and inflammation. In Induction of Inflammation: Cytokines and Acute-Phase Proteins, ed. by L. Schook and D. L. Laskin, pp. 71-96, Academic Press, San Diego.
43. Rose TM and Bruce AG (1991) Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc Natl Acad Sci USA 88:8641-8645.
44. Rose TM and Bruce AG (1994) Oncostatin M (OSM). In Cytokines and Their Receptors, ed. by N. A. Nicola, pp. 127-129, Oxford University Press, Oxford.
45. Shedlofsky S, Israel BC, McClain CJ, Hill DB and Blouin RA (1994) Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism. J Clin Invest 94:2209-2214.
46. Stadler J, Trockfeld J, Schmalix WA, Brill T, Siewert JR, Greim H and Doehmer J (1994) Inhibition of cytochromes P4501A by nitric oxide. Proc Natl Acad Sci USA 91:3559-3563.
47. Tinel M, Robin MA, Doostzadeh J, Maratrat M, Ballet F, Fardel N, El Kahwaji J, Beaune P, Daujat M, Labbe G and Pessayre D (1995) The interleukin-2 receptor down-regulated the expression of cytochrome P450 in cultured rat hepatocytes. Gastroenterology 109:1589-1599.
48. Waxman DJ, Lapenson DP, Aoyama T, Gelboin HV, Gonzalez FJ and Korzekwa K (1991) Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch Biochem Biosphys 290:160-166.
49. Williams JF, Bernent WJ, Sinclair JF and Sinclair PR (1991) Effect of interleukin 6 on phenobarbital induction of cytochrome P-450IIB in cultured rat hepatocytes. Biochem Biophys Res Commun 178:1049-1055.
50. Yun CH, Shimada T and Guengerich FP (1991) Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol 40:679-685.
51. Zarling JM, Shoyab M, Marquardt H, Hanson MB, Lion MN and Todaro GJ (1986) Oncostatin M; A growth regulator produced by differentiated histiocyte lymphoma cells. Proc Natl Acad Sci USA 83:9739-9743.